Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)
NCT06402708
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
172
Enrollment
OTHER
Sponsor class
Conditions
Thymic Carcinoma
Interventions
DRUG:
Chemotherapy
RADIATION:
Radiotherapy
Sponsor
Fudan University